Evaluation of PIK3CA mutation as a predictor of benefit from nonsteroidal anti-inflammatory drug therapy in colorectal cancer

E. Domingo, D. N. Church, O. Sieber, R. Ramamoorthy, Y. Yanagisawa, E. Johnstone, B. Davidson, D. J. Kerr, I. P. Tomlinson, R. Midgley

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)4297-305
JournalJournal of Clinical Oncology
Issue number34
Publication statusPublished - 2013

Cite this